Whether weight loss injections are "worth the money" depends on your health goals, your starting point, and whether a prescriber judges treatment clinically appropriate for you. For many people living with obesity or a weight-related health condition, the clinical results seen in trials — and the knock-on benefits for conditions like high blood pressure and type 2 diabetes — can justify the monthly cost, but these are prescription-only medicines and not a decision to make on price alone.
This guide breaks down what you actually pay in the UK, what the evidence shows, the hidden costs people forget, and how to decide sensibly rather than emotionally.
What do weight loss injections cost in the UK?
Prices vary by medicine and dose, because you typically start low and increase gradually. At The Weight Clinic, the online consultation is free and you only pay if a treatment is prescribed and you choose to proceed.
| Treatment | Form | From (per month) |
|---|---|---|
| Mounjaro (tirzepatide) | Weekly injection | £160 |
| Wegovy (semaglutide) | Weekly injection | £115 |
| Wegovy Tablet (oral semaglutide) | Daily tablet | £115 |
| Foundayo (orforglipron) | Daily tablet | £115 |
Because treatment is titrated upwards, the cost usually rises as your dose increases. Mounjaro, for example, ranges from £160 at the 2.5mg starter dose up to £295 at the 15mg maximum. Wegovy injection ranges from £115 to £245. It is worth planning for a mid-range monthly cost rather than only the starter price.
What results does the evidence actually show?
The honest answer is that results are significant in clinical trials — but they are averages, achieved alongside lifestyle support, and your own outcome may differ.
- Mounjaro: In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
- Wegovy injection: In the STEP UP clinical trial, adults on the 7.2mg dose lost on average 20.7% of their body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
- Wegovy Tablet: In the OASIS 4 trial, adults on oral semaglutide 25mg lost on average 16.6% of their body weight over 64 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
- Foundayo (orforglipron): In the Phase 3 ATTAIN-1 trial, participants on the 36mg dose lost on average 12.4% of their body weight over 72 weeks, alongside lifestyle counselling. Individual results vary; not everyone reaches this. (Note: 36mg is the trial capsule dose, above the UK maximum tablet strength of 17.2mg.)
These figures are not a cure for obesity, and they are not head-to-head comparisons. They do, however, give a sense of the scale of change possible when treatment is suitable and used as directed.
How these medicines work — and why that matters for value
Understanding the mechanism helps you judge whether you are paying for something meaningful rather than a gimmick.
Wegovy (both the injection and the tablet) is a GLP-1 receptor agonist — it mimics a natural gut hormone that controls appetite, so you feel fuller sooner and for longer, and the stomach empties more slowly. Mounjaro activates two gut-hormone receptors, GLP-1 and GIP, at the same time. Foundayo is a small-molecule GLP-1 receptor agonist taken as an ordinary once-daily pill, at any time of day, with or without food or water.
In other words, you are paying for a medicine that works on the biology of appetite, not willpower alone. That is a key reason many people find these treatments effective where diets have repeatedly failed.
The hidden costs people forget
A fair value judgement includes more than the sticker price:
- Duration: These are long-term treatments. Weight can return if medication stops, so budget for months, not weeks.
- Dose increases: Your monthly cost often rises as your dose goes up.
- Lifestyle support: The best results in trials came alongside changes to diet and activity, so the medicine complements effort rather than replacing it.
- Side effects: Common effects (in more than 1 in 10 people) include nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These are usually manageable but worth factoring into your decision.
Rare but serious risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia, severe gastrointestinal disease and worsening diabetic retinopathy. If you experience side effects, you can report them via the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
Are they worth it for YOU? A practical checklist
These treatments are most likely to represent good value if you meet the eligibility criteria and a prescriber agrees they are appropriate. Eligibility generally means you are:
- Aged 18 or over;
- Living with a BMI of 30 or above (obesity), or a BMI of 27–30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
They are not suitable if you are pregnant, planning pregnancy or breastfeeding; have type 1 diabetes; have a personal or family history of medullary thyroid carcinoma or MEN2; have a history of pancreatitis; have severe gastrointestinal disease; have an active eating disorder; have severe liver or kidney impairment; or are allergic to the active ingredient.
If you have tried to lose weight without lasting success and carry health risks linked to your weight, the potential benefit to your overall health is where much of the real "value" lies — not just the number on the scales.
How to avoid wasting money
The biggest financial risk isn't the medicine — it's buying from the wrong place. To protect your money and your health:
- Use a GPhC-registered UK pharmacy and check its registration on the General Pharmaceutical Council register.
- Make sure every treatment is prescribed by a registered prescriber after a proper consultation — not sold over the counter or shipped without checks.
- Avoid unlicensed or "grey-market" products advertised cheaply online; genuine value comes from genuine, MHRA-licensed medicines.
At The Weight Clinic, medicines are dispensed by our own GPhC-registered pharmacy (North Harrow Pharmacy, registration 1034996), and every treatment is reviewed by a GPhC-registered independent prescriber. You can read more about us or browse the full range on our treatments and weight loss injections pages.
The bottom line
Weight loss injections can be worth the money for the right person — someone who is clinically eligible, committed to the long term, and treating weight as a health issue rather than a cosmetic one. For others, they may not be suitable at all. The only way to know is a clinical assessment.
The consultation is free and there is no obligation to proceed. A prescription is only issued if treatment is clinically appropriate — it is never guaranteed. Start your free consultation to find out whether treatment could be right for you, or get in contact with any questions.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
